STICON 2013 - 2013 International Scientific STI Policy Evaluation Conference

New policy approaches in Science, Technology and Innovation (STI), new instruments as well as pressuring societal demands raised by economic actors and civil society challenge inclusive STI policies to deliver discernible social, economic and ecological benefits of R&D in effective ways. This will not only require new thinking in terms of STI evaluation designs, methodological diversity and interaction between policy-making and evaluation studies but also between STI governance, public management and society in general.
The international conference "Evaluation of STI policies, instruments and organisations: new horizons and new challenges" addresses these challenges in six dedicated thematic sessions:
Frameworks and approaches for evaluating new STI policies and instruments
The challenge of evaluating STI policy portfolios
Evaluation of mission-orientated R&D
Assessing the variety and long-term impact of research
Challenges in assessing new European Research Area policies, programmes and instruments
Information systems and STI indicators
Central questions addressed during the conference are:
What are adequate evaluations concepts, methodologies and practices vis-à-vis new political STI policy approaches?
What kind of evaluations is needed to respond to new STI policy-delivery models?
Whether and how can transformative effects of new mission-oriented approaches be identified and assessed?
By which criteria should funding bodies evaluate research on grand societal challenges, and how ‘political’ become evaluations and criteria in such policy-driven framework?
How can long-term effects of STI interventions be measured and the social impact of R&D be better appraised?
What are the evaluation challenges of ERA level policies and instruments?
What new approaches and assessment criteria are needed to meet the requirements of new instruments and institutions with a truly European pretence?
How do ERA developments interfere with national level evaluation?
What new indicators are needed to support the evaluation of new national, European and international STI policies?
How should research information systems be meaningfully designed to be useful for next-generation monitoring and evaluation?